Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo

被引:61
|
作者
Kidd, Martha E. [2 ]
Shin, Seungjin [1 ]
Shea, Lonnie D. [1 ,3 ]
机构
[1] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
关键词
Lentivirus; Fibrin; Hydroxyapatite; Tissue engineering; Nanoparticle; VECTOR DELIVERY; PLASMID DNA; SCAFFOLD; EXPRESSION; RELEASE; MATRICES; COLLAGEN; CARRIERS; GELATIN;
D O I
10.1016/j.jconrel.2011.08.036
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gene delivery from hydrogels represents a versatile approach for localized expression of tissue inductive factors that can promote cellular processes that lead to regeneration. Lentiviral gene therapy vectors were entrapped within fibrin hydrogels, either alone or complexed with hydroxylapatite (HA) nanoparticles. The inclusion of HA into the hydrogel led to the formation of small aggregates distributed throughout the hydrogel, with no obvious alteration of the pore structure outside the aggregates. The presence of HA slowed hydrogel degradation by collagenase and plasmin relative to fibrin alone, and also decreased the rate of cell migration. Lentivirus had similar release from the fibrin hydrogels formed with or without HA. The altered hydrogel properties suggest an interaction between the nanoparticle and fibrin, which may displace the virus from the particle leading to similar release profiles. Transgene expression by cells migrating into the hydrogel in vitro was reduced in the presence of HA, consistent with the role of cell migration on transgene expression. In vivo, lentivirus loaded fibrin hydrogels promoted localized transgene expression that increased through day 9 and decreased through day 14. For the fibrin only hydrogels, expression continued to decline after day 14. However, hydrogels with HA maintained this transgene expression level for an additional 2 weeks before declining. Immunostaining identified transgene primarily outside the fibrin-HA gel at day 9; however, at day 21, transgene expression was observed primarily within the fibrin-HA gel. The localized delivery of lentivirus provides an opportunity to enhance the bioactivity of fibrin hydrogels for a wide range of applications in regenerative medicine. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 50 条
  • [31] Intraosseous Delivery of Lentiviral Virus Acts as a Therapeutic Strategy for In Vivo Gene Therapy of Hemophilia
    Wang, Xuefeng
    Sign, Swati
    Kiem, Hans-Peter
    Rawlings, David J.
    Miao, Carol H.
    MOLECULAR THERAPY, 2018, 26 (05) : 278 - 278
  • [32] Lentiviral vectors for gene delivery into cells
    Quinonez, R
    Sutton, RE
    DNA AND CELL BIOLOGY, 2002, 21 (12) : 937 - 951
  • [33] Interleukin gene delivery for cancer gene therapy: In vitro and in vivo studies
    Azimifar, Mohammad Amin
    Hashemi, Maryam
    Babaei, Nahid
    Salmasi, Zahra
    Doosti, Abbas
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (02) : 128 - 138
  • [34] Lentiviral vectors for in vivo gene therapy
    Mitrophanous, Kyriacos
    Palfi, S.
    Lauer, A.
    Campochiaro, P.
    Gurruchaga, J. M.
    Watts, C.
    Buttery, P. C.
    Sohn, E.
    Lepetit, H.
    Kelleher, M.
    Harrop, R.
    Badin, R. A.
    Binley, K.
    Howard, K.
    Camp, N. V.
    Jan, C.
    Stewart, H.
    Scott, G. R.
    Lad, Y.
    Loader, J.
    Tuckwell, N.
    Hosomi, K.
    Barker, R. A.
    Ellis, S.
    Miskin, J.
    Hantraye, P.
    HUMAN GENE THERAPY, 2018, 29 (07) : A3 - A4
  • [35] Transgene expression from CpG-reduced lentiviral gene delivery vectors in vitro
    Low, Poh Tee
    Lai, Mei I.
    Ngai, Siew Ching
    Abdullah, Syahril
    GENE, 2014, 533 (01) : 451 - 455
  • [36] Evaluation of Lentiviral Based Gene Delivery System in Adherent and Suspension in vitro Cell Models
    Idris, Izyan Mohd
    Nordin, Fazlina
    Muhamad, Nur Jannaim
    Idris, Siti Zuleha
    Tye, Gee Jun
    Zaman, Wan Safwani Wan Kamarul
    Ng, Min Hwei
    SAINS MALAYSIANA, 2024, 53 (03): : 549 - 559
  • [37] Non viral vector delivery in vitro using fibrin hydrogels (vol 136, pg 87, 2009)
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2009, 139 (03) : 246 - 246
  • [38] An in vitro and in vivo comparison of lentiviral vectors for gene therapy of sickle-cell disease
    Urbinati, F.
    Poletti, V.
    Fernandez, B. C.
    Martin, S.
    Hollis, R. P.
    Koziol, C.
    Kaufman, M. L.
    Brown, D.
    Miccio, A.
    Antoniou, M.
    Mavilio, F.
    Kohn, D. B.
    HUMAN GENE THERAPY, 2016, 27 (11) : A113 - A114
  • [39] Intrathecal Drug Delivery Platform for Gene Therapy: An In Vitro & In Vivo Delivery Study
    Freund, Jonathan
    Singh, Deep A.
    Arzumand, Ayesha
    Sass, Lucas
    Byass, Shayaine
    Matin, Bryn
    Anand, P. J.
    MOLECULAR THERAPY, 2018, 26 (05) : 286 - 287
  • [40] In vivo gene transfer into adult stem cells in unconditioned mice by lentiviral in situ delivery of a vector
    Worsham, D. Nicole
    Schuesler, Todd
    von Kalle, Christof
    Pan, Dao
    MOLECULAR THERAPY, 2006, 14 (04) : 514 - 524